Corbus Pharmaceuticals Holdings, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Corbus Pharmaceuticals Holdings, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 2.0 times its market value (net cash). Higher than 95% of Healthcare companies in United States.
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-39.5×Operating cash was negative last year, while some debt falls due within a year.
Lower than 68% of Healthcare companies in United States.
Cash Cushion Ratio
2.0× cashCash, after subtracting all debt, is 2.0 times its market value (net cash).
Higher than 95% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Corbus Pharmaceuticals Holdings, Inc. made a loss over the last year. Corbus Pharmaceuticals Holdings, Inc. owes $0.19 for every $1 it owns. Corbus Pharmaceuticals Holdings, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossCorbus Pharmaceuticals Holdings, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.78The share price is 0.78 times Corbus Pharmaceuticals Holdings, Inc.'s book value per share, lower than 85% of Healthcare companies in United States.
Market cap
$80 MThe total market value of all of Corbus Pharmaceuticals Holdings, Inc.'s shares at today's price (share price × number of shares), smaller than 69% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$102 MWhat Corbus Pharmaceuticals Holdings, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$5.29Net worth divided by the number of shares. The share price of $4.13 is 0.8 times this, which is the P/B above.
Return on equity (ROE)
-95.6%Corbus Pharmaceuticals Holdings, Inc. lost 95.6% of its shareholders' money over the last year, lower than 69% of Healthcare companies in United States.
Owes vs Owns
0.19×Corbus Pharmaceuticals Holdings, Inc. owes $0.19 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Dividend yield
NoneCorbus Pharmaceuticals Holdings, Inc. does not currently pay a dividend.
Profit growth
LossCorbus Pharmaceuticals Holdings, Inc. made a loss in each of the last two years.
Cash vs debt
Net cashCorbus Pharmaceuticals Holdings, Inc. held $162 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Corbus Pharmaceuticals Holdings, Inc.: $80 M ÷ $102 M (30 Jun 2026) = 0.8.
What is Corbus Pharmaceuticals Holdings, Inc.'s return on equity?
Corbus Pharmaceuticals Holdings, Inc. lost 95.6% of its shareholders' money over the last year, lower than 69% of Healthcare companies in United States.
How much does Corbus Pharmaceuticals Holdings, Inc. owe compared with what it owns?
Corbus Pharmaceuticals Holdings, Inc. owes $0.19 for every $1 it owns (low), lower than 73% of Healthcare companies in United States.
Does Corbus Pharmaceuticals Holdings, Inc. pay a dividend?
No. Corbus Pharmaceuticals Holdings, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.